ROYALTY PHARMA PLC

Ticker: RPRX CUSIP: G7709Q104 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 396,738 Value ($000) $15,330 Avg Close $38.13 Range $35.23 - $41.24
Q3 2025
Shares 1,483,676 Value ($000) $52,344 Avg Close $36.20 Range $34.08 - $38.00
Q2 2024
Shares 945,840 Value ($000) $24,942 Avg Close $27.72 Range $26.11 - $30.55
Q1 2024
Shares 1,455,900 Value ($000) $44,216 Avg Close $29.48 Range $27.16 - $31.66
Q4 2023
Shares 1,440,043 Value ($000) $40,451 Avg Close $27.48 Range $26.07 - $29.63
Q3 2023
Shares 164,810 Value ($000) $4,473 Avg Close $29.70 Range $25.92 - $31.55
Q2 2023
Shares 1,806,621 Value ($000) $55,536 Avg Close $33.87 Range $29.20 - $36.73
Q1 2023
Shares 672,530 Value ($000) $24,231 Avg Close $37.08 Range $32.68 - $39.92
Q3 2022
Shares 432,250 Value ($000) $17,368 Avg Close $42.71 Range $39.60 - $44.66
Q1 2022
Shares 74,655 Value ($000) $2,910 Avg Close $39.27 Range $36.15 - $42.62
Q4 2021
Shares 190,846 Value ($000) $7,605 Avg Close $38.85 Range $34.86 - $43.68
Q3 2021
Shares 1,201,980 Value ($000) $43,440 Avg Close $38.86 Range $35.55 - $42.89
Q3 2020
Shares 29,255 Value ($000) $1,231 Avg Close $42.91 Range $38.54 - $48.88